Treatment Options From 5 Experts for Patients With HER2-Positive Early-Stage Breast Cancer

Were you recently diagnosed with HER2-positive early-stage breast cancer? CCO and GRACE have partnered to develop a Treatment Decision Support Tool to help you understand more about your cancer diagnosis and treatment options. Answer these multiple choice questions to see treatment plans from 5 oncology experts.
Frankie Ann Holmes, MD, FACP
Sara Hurvitz, MD, FACP
Joyce O'Shaughnessy, MD
Mark D. Pegram, MD
Denise A. Yardley, MD

Patient-focused Interactive Decision Support Tool

Did you recently receive a diagnosis of HER2-positive early breast cancer? Use this Interactive Decision Support Tool to view treatment plans before or after surgery from 5 breast cancer experts by answering a series of multiple choice questions about your cancer.

Frankie Ann Holmes, MD, FACP Sara Hurvitz, MD, FACP Joyce O'Shaughnessy, MD Mark D. Pegram, MD Denise A. Yardley, MD Released: March 19, 2019
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Produced in collaboration with
Grace Logo
This activity is supported by an educational grant from
Genentech

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue